Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Chrysophanics, referring to compounds like chrysophanol primarily found in certain plants such as Rheum and Cassia species, have a history of use in traditional medicine for various skin conditions, including dermatitis. Modern scientific validation is limited but present. Chrysophanol exhibits anti-inflammatory and antimicrobial properties, which are relevant to the pathology of dermatitis. In vitro and animal studies have demonstrated that chrysophanol can inhibit pro-inflammatory cytokines and reduce skin inflammation. For example, research published in Biological & Pharmaceutical Bulletin (2010) showed that chrysophanol suppressed inflammation in a mouse model of atopic dermatitis by reducing levels of IL-4 and IgE. However, robust clinical trials in humans are lacking, and most evidence comes from preclinical studies or traditional use in herbal ointments. The European Medicines Agency and major dermatological guidelines do not currently recognize chrysophanics as an established treatment for dermatitis. In summary, while preliminary scientific evidence supports the anti-inflammatory potential of chrysophanics for dermatitis, the evidence base is weak (rating 2/5), and further research, especially well-designed human trials, is needed to confirm efficacy and safety for this indication.

More about Chrysophanics
More about Dermatitis

Other ingredients used for Dermatitis

Other health conditions supported by Chrysophanics

Products containing Chrysophanics